Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop ...

New research from the University of Cambridge reveals that a gene fault linked to a rare condition may be far more common ...

An annual blood test could prevent around half of cancer cases from reaching an advanced stage, new research suggests.

A Tucson woman is sharing her personal story — and a warning — in honor of Melanoma Monday and Skin Cancer Awareness Month.

Continued oncology pipeline advancement with a strategic focus on two priority pan-tumor programs: next-generation immunomodulator BNT327, a bispecific antibody targeting PD-L1 and VEGF-A1, and mRNA c ...

A bus whose passengers include a team of healthcare experts is travelling to towns and cities to raise awareness of cancer ...

Some 50,000 Australians will die from cancer this year, despite big breakthroughs in treatments. What makes cancer so very ...

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...

The deal brings Roche into competition with Eli Lilly, whose RET inhibitor selpercatinib is already approved by the FDA under the brand name Retevmo in RET-mutated lung cancer and two ...

The overall survival (OS) data has come in from the TROPION-Lung01 study of AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan (Dato-DXd) in lung cancer ... have been signs that the ...